Relation of multiple inflammatory biomarkers to incident atrial fibrillation. - Wikidata - wikimedia - TriplyDB

Relation of multiple inflammatory biomarkers to incident atrial fibrillation.

Relation of multiple inflammatory biomarkers to incident atrial fibrillation.

http://www.wikidata.org/entity/Q33573035

about

EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases Association of sex hormones, aging, and atrial fibrillation in men: the Framingham Heart Study.Are cardiovascular risk factors also associated with the incidence of atrial fibrillation? A systematic review and field synopsis of 23 factors in 32 population-based cohorts of 20 million participants.Body mass index and risk of left atrial thrombus in patients with atrial fibrillation.A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies.The expression levels of plasma micoRNAs in atrial fibrillation patients.Multiple biomarkers and atrial fibrillation in the general population Meta-analysis of genome-wide association studies identifies two loci associated with circulating osteoprotegerin levels Multiple inflammatory biomarker detection in a prospective cohort study: a cross-validation between well-established single-biomarker techniques and an electrochemiluminescense-based multi-array platform Depression in atrial fibrillation in the general population.New-onset atrial fibrillation after acute myocardial infarction and its relation to admission biomarkers (from the TRIUMPH registry).Effects of body mass index on risks for ischemic stroke, thromboembolism, and mortality in Chinese atrial fibrillation patients: a single-center experience.Atrial fibrillation: current knowledge and future directions in epidemiology and genomics.Large-scale candidate gene analysis in whites and African Americans identifies IL6R polymorphism in relation to atrial fibrillation: the National Heart, Lung, and Blood Institute's Candidate Gene Association Resource (CARe) project.Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013.Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.Predictors of atrial fibrillation recurrence after cryoballoon ablation.Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes.Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation.Excavatolide B Modulates the Electrophysiological Characteristics and Calcium Homeostasis of Atrial Myocytes.Atrial Fibrillation and Declining Physical Performance in Older Adults: The Health, Aging, and Body Composition Study.Clinical correlates of change in inflammatory biomarkers: The Framingham Heart Study.Elevated plasma levels of Th17-related cytokines are associated with increased risk of atrial fibrillation Circulating Biomarkers Predictive of Postoperative Atrial Fibrillation.The risk of atrial fibrillation in patients with rheumatoid arthritis Targeting inflammation and oxidative stress in atrial fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins.Biomarkers in atrial fibrillation: a clinical review.Biomarkers in atrial fibrillation: an overview.Cardioembolic stroke diagnosis using blood biomarkers.Inflammation and the pathogenesis of atrial fibrillation.CHA2DS2-VASc Score: A Predictor of Thromboembolic Events and Mortality in Patients With an Implantable Monitoring Device Without Atrial Fibrillation.Role of tumor necrosis factor alpha in the pathogenesis of atrial fibrillation: A novel potential therapeutic target?Association Between Vascular Cell Adhesion Molecule 1 and Atrial Fibrillation.Associations of Abdominal Obesity and New-Onset Atrial Fibrillation in the General Population.Characteristics of PR interval as predictor for atrial fibrillation: association with biomarkers and outcomes.Atrial fibrillation, cognition and dementia: A review.Relations of Liver Fat With Prevalent and Incident Atrial Fibrillation in the Framingham Heart Study.Risk factors responsible for atrial fibrillation development between symptomatic patients with concealed or manifest atrioventricular accessory pathways.

P2860

Q30375302-EBDE78EE-10CF-4624-958C-2318B1B00B16 Q30419941-25F492AC-3AE3-479E-AC90-6820F5DA776E Q33668906-3B008E92-1FC5-4FDF-A568-8EFA81B737B7 Q33721705-5149FC52-82FD-4A41-9A09-8F33BC9C3A2E Q33951474-EE96A868-414A-43E6-9F5C-731963AD8F3F Q33992740-9A577636-4763-483B-8B30-6AAA31E43DF1 Q34342621-76A76DC0-CDC0-4ACA-8823-E17DBAE1E2AF Q34427635-F9557D9A-395C-4861-B85F-CF0D5448A819 Q34525092-E5EE21EA-563F-483A-83A7-432AD38793E5 Q34555532-070B18BD-DDAA-4788-BD11-A5F743035B8B Q34615040-5DC89ED4-0F7D-4B47-8C9F-089222A2FAFC Q35063678-C11BF199-C605-401B-AEC0-78E386274296 Q35068612-2FD528EA-805D-4E32-80AB-6183840F347D Q35305757-B2DAEAE1-C49F-40FA-9741-BFCA9B317B62 Q35526930-1D867342-29EC-46B6-A6D2-49CFE23B8E49 Q35575039-707A91E2-A0DA-41D5-894A-6B9A42F8DB6E Q35585789-C46B4A05-4284-4798-B14B-C8A0BE146861 Q35609742-086EC9A6-1DDF-4B58-9951-D9B1898575E7 Q35821956-1825B072-A375-4987-A169-A9C049253331 Q35926521-51703AC5-14F6-464F-B0C8-D28F929501FD Q36172879-79D86132-7E8F-4CB5-B803-E22287777548 Q36260790-B17696EA-149B-4249-99EB-4F85137C987B Q36784212-3E3D6C35-76A6-405C-BBF6-98DB4CF9673C Q36833592-CD6ADC8A-3399-413D-B51C-2B136D14926F Q36919277-85D676EA-6148-48DC-8B0F-24565BB052D2 Q37094015-FE81D693-7169-49C6-A352-C40F58C2BB60 Q37446317-5D2C3969-4B14-4C4F-9F4F-058C23FDE527 Q37602866-6C2F1ED6-5BB3-4B7A-9EB6-1EC7FC4C5BCD Q38079565-02E73FF8-B39B-4E3A-8BB2-F309A7A4FF24 Q38174213-79DDC110-6A25-4C3F-9766-55D25E7A2D7E Q38188010-EAC2F015-6505-4E50-A241-D3C2C057748A Q38333088-A220FBB2-534A-4AD6-A882-A2ED5738BE05 Q38372615-2EB39ACC-6B72-4C76-861A-0524ED662EC8 Q38486305-8D6FEBA6-D703-497E-8825-C51F71A55E41 Q38738095-DBA95ED2-AB27-4153-A352-75EBA841EF2E Q38739817-D9AE6968-E59B-4987-95ED-574BB1247832 Q39223539-08751FAF-2C29-4D8C-A4C4-C35F7C65134A Q39343435-821C506D-9FC9-4C20-868D-D602ECB5D5B3 Q40218239-0975E773-BAAD-4FDE-8179-B8203B7D02F3 Q40964057-A64B5B15-84FE-441A-8305-B5308FBF8AE9

P2860

Relation of multiple inflammatory biomarkers to incident atrial fibrillation.

http://www.wikidata.org/entity/Q33573035

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Relation of multiple inflammatory biomarkers to incident atrial fibrillation.

@ast

Relation of multiple inflammatory biomarkers to incident atrial fibrillation.

@en

Relation of multiple inflammatory biomarkers to incident atrial fibrillation.

@nl

type

label

Relation of multiple inflammatory biomarkers to incident atrial fibrillation.

@ast

Relation of multiple inflammatory biomarkers to incident atrial fibrillation.

@en

Relation of multiple inflammatory biomarkers to incident atrial fibrillation.

@nl

prefLabel

Relation of multiple inflammatory biomarkers to incident atrial fibrillation.

@ast

Relation of multiple inflammatory biomarkers to incident atrial fibrillation.

@en

Relation of multiple inflammatory biomarkers to incident atrial fibrillation.

@nl

P1433

Q33573035-7659058A-4237-411E-AE71-E63AA6584EA2

P1476

Q33573035-AD87F887-D8EE-4038-97DD-0243995545AA

P2093

Q33573035-1DA850BA-CC79-4B9A-96A3-D34D806FD14B

Q33573035-43322743-0C62-432B-804A-BBC1DEF6A933

Q33573035-53B64D74-232F-4D77-BE8B-52B8FDBDFD8C

Q33573035-8D3D2778-C009-4808-B1CB-57561DF40AEB

Q33573035-9B36C797-40EF-46F4-BB6D-42A928C2E927

Q33573035-EDCCF8C9-67D7-410D-AA26-B86A6EEAF3E1

P2860

Q33573035-0E73B1A3-DD36-4068-8A1D-90D05F968565

Q33573035-10809DF7-F69E-44CB-A166-E1D0A3652CC7

Q33573035-20B85DB0-EAD1-48D1-B573-CBE2B053F65D

Q33573035-23C2EE19-9C27-4638-8450-364514663582

Q33573035-47D2492A-7B90-487B-AF2A-0EF0E7A3B88E

Q33573035-4FD3FDF1-8DD3-41DA-9340-7040390D74D7

Q33573035-51A184CA-CA4D-4374-BEF9-B638E7A48563

Q33573035-68CDBC44-9A02-4369-AB20-EC51497469C1

Q33573035-81A8F3C6-BBF6-4657-AAFF-31BA88433085

Q33573035-A0008375-423F-42F3-8BFE-627752979C94

P304

Q33573035-63961946-CC3C-41BD-85CB-FD2E85AD77AB

P31

Q33573035-6C57A782-5EDB-45AA-AE06-7755782E5883

P356

Q33573035-3AF54B75-F055-4CCA-8B6D-ADEAE14BF85A

P407

Q33573035-D2FCBACF-3167-47B6-8222-C7CE39E9836C

P433

Q33573035-7E196837-AB21-4851-8BC0-68922A95B14A

P478

Q33573035-BCF4C9B6-0D01-43B9-9A9A-8B0F160DB581

P50

Q33573035-210FCAAA-0246-4649-B31C-A2D573DE90F2

Q33573035-4DA36759-39E0-4A0B-A322-2232C7BE4D9E

Q33573035-7261F4BE-638C-4113-8A63-D510F6604FBA

Q33573035-F36182BE-4965-4457-A224-B7747B28772D

P577

Q33573035-43F0BBC6-9A78-4412-B5C4-BBE5AEAFBE8A

P5875

Q33573035-9089693F-CCD9-4520-B115-2B5E7BA71C27

P698

Q33573035-9A9995DE-C967-432A-9DCD-DBFF3D4BFFF3

P921

Q33573035-5C3B3B12-1C08-41BB-8A3D-0F9CB9D1B5F1

Q33573035-7604921C-BE9B-4213-8D1D-AE96681142CB

Q33573035-7DCF6BFA-B66C-4827-8448-179802980A08

P932

Q33573035-7188842F-2973-4A1A-BBEA-E546A0C53E48

P356

J.AMJCARD.2009.02.053

P1433

American Journal of Cardiology

P1476

Relation of multiple inflammatory biomarkers to incident atrial fibrillation.

@en

P2093

Daniel Levy

http://www.w3.org/2001/XMLSchema#string

Jennifer F Yamamoto

http://www.w3.org/2001/XMLSchema#string

Jian Rong

http://www.w3.org/2001/XMLSchema#string

John F Keaney

http://www.w3.org/2001/XMLSchema#string

Renate B Schnabel

http://www.w3.org/2001/XMLSchema#string

Thomas J Wang

http://www.w3.org/2001/XMLSchema#string

P2860

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study.

The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

Relations of inflammatory biomarkers and common genetic variants with arterial stiffness and wave reflection

Inflammation as a risk factor for atrial fibrillation.

Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis.

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats.

Histological substrate of atrial biopsies in patients with lone atrial fibrillation.

Oxidative stress markers are associated with persistent atrial fibrillation

Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis.

P304

92-96

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AMJCARD.2009.02.053

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

Sekar Kathiresan

Emelia J. Benjamin

Ramachandran S. Vasan

Martin G Larson

P577

2009-05-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26646283

http://www.w3.org/2001/XMLSchema#string

P698

19576326

http://www.w3.org/2001/XMLSchema#string

P921

atrial fibrillation

P932

2802058

http://www.w3.org/2001/XMLSchema#string